Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.85B |
| 2 |
Tesla
TSLA
|
+$1.78B |
| 3 |
Apple
AAPL
|
+$1.57B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.49B |
| 5 |
Mastercard
MA
|
+$1.09B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.3B |
| 2 |
Phillips 66
PSX
|
+$650M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$475M |
| 4 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$432M |
| 5 |
NRG Energy
NRG
|
+$387M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.59% |
| 2 | Financials | 9.21% |
| 3 | Consumer Discretionary | 7.33% |
| 4 | Healthcare | 5.59% |
| 5 | Communication Services | 5.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4626
Vanguard Consumer Staples ETF
VDC
$7.97B
| $22.1K | ﹤0.01% |
101
-55
| -35% | -$11.9K |
|
|
IGMS
4627
DELISTED
IGM Biosciences
IGMS
| $22.1K | ﹤0.01% |
19,178
-7,125
| -27% | -$13.3K |
|
4628
Bakkt Inc
BKKT
$321M
| $21.6K | ﹤0.01% |
2,494
-2,597
| -51% | -$44.4K |
|
|
MAXN
4629
DELISTED
Maxeon Solar Technologies
MAXN
| $21.4K | ﹤0.01% |
7,253
-848
| -10% | -$4.3K |
|
4630
CI&T Inc
CINT
$431M
| $21.2K | ﹤0.01% |
+3,547
| New | +$23.8K |
|
|
IDAT
4631
DELISTED
iShares Future Cloud 5G and Tech ETF
IDAT
| $21.1K | ﹤0.01% |
700
| – | – |
|
|
CMLS
4632
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $21K | ﹤0.01% |
47,511
-1,826
| -4% | -$1.32K |
|
4633
Outlook Therapeutics
OTLK
$183M
| $20.8K | ﹤0.01% |
17,040
-6,840
| -29% | -$12K |
|
4634
ProShares Ultra QQQ
QLD
$12.7B
| $20.4K | ﹤0.01% |
460
-1,454
| -76% | -$76.9K |
|
4635
Karyopharm Therapeutics
KPTI
$43.5M
| $19.9K | ﹤0.01% |
5,333
-1,041
| -16% | -$8.89K |
|
4636
Ovid Therapeutics
OVID
$414M
| $19.9K | ﹤0.01% |
63,918
-29,389
| -31% | -$18.1K |
|
4637
Magnachip Semiconductor
MX
$119M
| $19.8K | ﹤0.01% |
5,782
| – | – |
|
4638
M-tron Industries
MPTI
$356M
| $19.8K | ﹤0.01% |
445
-1,612
| -78% | -$76.5K |
|
4639
UNIFI
UFI
$119M
| $19.7K | ﹤0.01% |
4,099
-4,983
| -55% | -$27.9K |
|
4640
Verrica Pharmaceuticals
VRCA
$89.7M
| $19.6K | ﹤0.01% |
4,438
+1,437
| +48% | +$9.29K |
|
|
BSIIU
4641
DELISTED
Black Spade Acquisition II Co Unit
BSIIU
| $19.6K | ﹤0.01% |
2,059
-10
| -0.5% | -$101 |
|
|
SLN
4642
Silence Therapeutics
SLN
$495M
| $19.3K | ﹤0.01% |
6,854
+728
| +12% | +$3.56K |
|
4643
Comscore
SCOR
$106M
| $19.2K | ﹤0.01% |
2,795
-1,215
| -30% | -$8.13K |
|
4644
Exagen
XGN
$109M
| $18.5K | ﹤0.01% |
5,145
| – | – |
|
|
ALFUU
4645
Centurion Acquisition Corp Unit
ALFUU
| $18.4K | ﹤0.01% |
1,791
-709
| -28% | -$7.27K |
|
4646
Prelude Therapeutics
PRLD
$366M
| $17.8K | ﹤0.01% |
23,145
-6,628
| -22% | -$6.18K |
|
|
AXIA
4647
AXIA Energia
AXIA
$23.9B
| $17.8K | ﹤0.01% |
3,157
-9,531
| -75% | -$48.5K |
|
|
DGNX
4648
Diginex Ltd
DGNX
$44.5M
| $17.7K | ﹤0.01% |
+200
| New | +$11.3K |
|
|
AMRN
4649
Amarin Corp
AMRN
$299M
| $17.7K | ﹤0.01% |
1,976
+312
| +19% | +$3.3K |
|
|
DOYU
4650
DouYu International Holdings
DOYU
$139M
| $17.6K | ﹤0.01% |
+2,358
| New | +$27K |
|
Similar funds
Barclays's Q1 2025 Portfolio in Review
As of Q1 2025, Barclays held 5,710 positions worth $353B, down 1.2% from $357B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $16.5B of net new capital in Q1 2025, opening 439 new positions and adding to 1,449 existing holdings. Its largest new stake was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.3B trimmed.
- Barclays's largest Q1 2025 buy was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $3.85B increase.
- Barclays's biggest Q1 2025 reduction was Honeywell, cutting an estimated $1.3B.
- Barclays fully exited Smartsheet Inc. in Q1 2025, selling an estimated $45.7M.
- Barclays's ten largest holdings make up 37% of its $353B portfolio in Q1 2025.
- Barclays opened 439 new positions and closed 470 in Q1 2025.
- Barclays's portfolio value fell 1.2% quarter-over-quarter to $353B.
Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.